LLY

Q: What is the price of Eli Lilly (LLY) today?

The current price of Eli Lilly (LLY) is $ 959.08, representing a 34.01% gain over the past year. The stock began the year trading around $ 1,074.68 and is currently priced at $ 959.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Eli Lilly (LLY) pay dividends?

In the last year, Eli Lilly (LLY) distributed dividends in the month of March, totaling $ 1.73. The Dividend Yield for the last 12 months is 0.67%.

Q: Is Eli Lilly (LLY) a good investment?

Eli Lilly (LLY) is currently trading at $ 959.08 with a P/E ratio of 40.57%. This represents a 6,392% premium compared to its historical average P/E. Over the past year, the stock has gained 34.01 and paid $ 1.73 in dividends, resulting in a dividend yield of 0.67%. The total shareholder return over the same period was 34.01%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Eli Lilly and Compay

Price

$ 959.08

return (12m)

34.01%

p/e

40.57

p/bv

35.11

DIVIDEND YIELD

0.67%

LLY price

LLY

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment LLY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-4.22%

3 months

-9.67%

1 year

34.01%

2 years

27.62%

5 years

454.34%

10 years

1,418.92%

Fundamentals LLY

review the fundamentals of Eli Lilly shares

P/E

40.57

Sector: -2.15 Industry: 0.38

P/S (PSR)

12.85

Sector: 1.92 Industry: 2.43

P/BV

35.11

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

0.67%

Sector: - Industry: -

ROA

0.00%

Sector: -25.33% Industry: -23.48%

ROE

86.53%

Sector: -29.65% Industry: -31.19%

ROIC

39.16%

Sector: -418.66% Industry: -76.94%

NET MARGIN

31.66%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

83.04%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

46.06%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

29.34

Sector: -0.40 Industry: 1.11

EV/EBIT

30.87

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

Sector: 1.13 Industry: 1.20

BVPS

26.65

Sector: 3.83 Industry: 5.09

EPS

23.06

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

18.14%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

29.89%

Sector: - Industry: -

FAIR VALUE OF Eli Lilly ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 959.08

Fair Value

$ 0.00

Upside/Downside Return potential.

-87.74%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals LLY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%
CI	10.45	0.00	0.00%	2.26%	$ 71.83 B	2.50%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

LLY Historical Dividends

current DY: 0.67%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/13/2026	03/10/2026	1,73000000
Dividends	11/14/2025	12/10/2025	1,50000000
Dividends	08/15/2025	09/10/2025	1,50000000
Dividends	05/16/2025	06/10/2025	1,50000000
Dividends	02/14/2025	03/10/2025	1,50000000
Dividends	11/15/2024	12/10/2024	1,30000000
Dividends	08/15/2024	09/10/2024	1,30000000
Dividends	05/16/2024	06/10/2024	1,30000000
Dividends	02/15/2024	03/08/2024	1,30000000
Dividends	11/15/2023	12/08/2023	1,13000000
Dividends	08/15/2023	09/08/2023	1,13000000
Dividends	05/15/2023	06/09/2023	1,13000000
Dividends	02/15/2023	03/10/2023	1,13000000
Dividends	11/15/2022	12/09/2022	0,98000000
Dividends	08/15/2022	09/09/2022	0,98000000
Dividends	05/16/2022	06/10/2022	0,98000000
Dividends	02/15/2022	03/10/2022	0,98000000
Dividends	11/15/2021	12/10/2021	0,85000000
Dividends	08/13/2021	09/10/2021	0,85000000
Dividends	05/14/2021	06/10/2021	0,85000000
Dividends	02/12/2021	03/10/2021	0,85000000
Dividends	11/13/2020	12/10/2020	0,74000000
Dividends	08/14/2020	09/10/2020	0,74000000
Dividends	05/15/2020	06/10/2020	0,74000000
Dividends	02/14/2020	03/10/2020	0,74000000
Dividends	11/15/2019	12/10/2019	0,64500000
Dividends	08/15/2019	09/10/2019	0,64500000
Dividends	05/17/2019	06/10/2019	0,64500000
Dividends	02/15/2019	03/08/2019	0,64500000
Dividends	11/15/2018	12/10/2018	0,56300000
Dividends	08/15/2018	09/10/2018	0,56300000
Dividends	05/17/2018	06/08/2018	0,56300000
Dividends	02/15/2018	03/09/2018	0,56300000
Dividends	11/15/2017	12/08/2017	0,52000000
Dividends	08/15/2017	09/08/2017	0,52000000
Dividends	05/15/2017	06/09/2017	0,52000000
Dividends	02/15/2017	03/10/2017	0,52000000
Dividends	11/15/2016	12/09/2016	0,51000000
Dividends	08/15/2016	09/09/2016	0,51000000
Dividends	05/13/2016	06/10/2016	0,51000000
Dividends	02/12/2016	03/10/2016	0,51000000
Dividends	11/13/2015	12/10/2015	0,50000000
Dividends	08/14/2015	09/10/2015	0,50000000
Dividends	05/18/2015	06/10/2015	0,50000000
Dividends	02/13/2015	03/10/2015	0,50000000
Dividends	11/14/2014	12/10/2014	0,49000000
Dividends	08/15/2014	09/10/2014	0,49000000
Dividends	05/15/2014	06/10/2014	0,49000000
Dividends	02/14/2014	03/10/2014	0,49000000
Dividends	11/15/2013	12/10/2013	0,49000000
Dividends	08/15/2013	09/10/2013	0,49000000
Dividends	05/16/2013	06/10/2013	0,49000000
Dividends	02/15/2013	03/08/2013	0,49000000
Dividends	11/15/2012	12/10/2012	0,49000000
Dividends	08/15/2012	09/10/2012	0,49000000
Dividends	05/15/2012	06/08/2012	0,49000000
Dividends	02/15/2012	03/09/2012	0,49000000
Dividends	11/15/2011	12/09/2011	0,49000000
Dividends	08/15/2011	09/09/2011	0,49000000
Dividends	05/13/2011	06/10/2011	0,49000000
Dividends	02/15/2011	03/10/2011	0,49000000
Dividends	11/15/2010	12/10/2010	0,49000000
Dividends	08/13/2010	09/10/2010	0,49000000
Dividends	05/14/2010	06/10/2010	0,49000000
Dividends	02/12/2010	03/10/2010	0,49000000
Dividends	11/13/2009	12/10/2009	0,49000000
Dividends	08/15/2009	09/10/2009	0,49000000
Dividends	05/15/2009	06/10/2009	0,49000000
Dividends	02/13/2009	03/10/2009	0,49000000
Dividends	11/14/2008	12/10/2008	0,47000000
Dividends	08/15/2008	09/10/2008	0,47000000
Dividends	05/15/2008	06/10/2008	0,47000000
Dividends	02/15/2008	03/10/2008	0,47000000
Dividends	11/15/2007	12/10/2007	0,42500000
Dividends	08/15/2007	09/10/2007	0,42500000
Dividends	05/15/2007	06/08/2007	0,42500000
Dividends	02/15/2007	03/09/2007	0,42500000
Dividends	11/15/2006	12/08/2006	0,40000000
Dividends	08/15/2006	09/08/2006	0,40000000
Dividends	05/15/2006	06/09/2006	0,40000000
Dividends	02/15/2006	03/10/2006	0,40000000
Dividends	11/15/2005	12/09/2005	0,38000000
Dividends	08/15/2005	09/09/2005	0,38000000
Dividends	05/13/2005	06/10/2005	0,38000000
Dividends	02/15/2005	03/10/2005	0,38000000
Dividends	11/15/2004	12/10/2004	0,35500000
Dividends	08/13/2004	09/10/2004	0,35500000
Dividends	05/14/2004	06/10/2004	0,35500000
Dividends	02/13/2004	03/10/2004	0,35500000
Dividends	11/14/2003	12/10/2003	0,33500000
Dividends	08/15/2003	09/10/2003	0,33500000
Dividends	05/15/2003	06/10/2003	0,33500000
Dividends	02/14/2003	03/10/2003	0,33500000
Dividends	11/15/2002	12/10/2002	0,31000000
Dividends	08/15/2002	09/10/2002	0,31000000
Dividends	05/15/2002	06/10/2002	0,31000000
Dividends	02/15/2002	03/08/2002	0,31000000
Dividends	11/15/2001	12/10/2001	0,28000000
Dividends	08/15/2001	09/10/2001	0,28000000
Dividends	05/15/2001	06/11/2001	0,28000000
Dividends	02/15/2001	03/09/2001	0,28000000
Dividends	11/15/2000	12/11/2000	0,26000000
Dividends	08/15/2000	09/11/2000	0,26000000
Dividends	05/15/2000	06/09/2000	0,26000000
Dividends	02/15/2000	03/10/2000	0,26000000
Dividends	11/15/1999	12/10/1999	0,23000000
Dividends	08/13/1999	09/10/1999	0,23000000
Dividends	05/14/1999	06/10/1999	0,23000000
Dividends	02/12/1999	03/10/1999	0,23000000
Dividends	11/13/1998	12/10/1998	0,20000000
Dividends	08/14/1998	09/10/1998	0,20000000
Dividends	05/15/1998	06/10/1998	0,20000000
Dividends	02/13/1998	03/10/1998	0,20000000
Dividends	11/14/1997	12/10/1997	0,20000000
Dividends	08/15/1997	09/10/1997	0,18000000
Dividends	05/15/1997	06/10/1997	0,18000000
Dividends	02/14/1997	03/10/1997	0,18000000
Dividends	11/15/1996	12/10/1996	0,17100000
Dividends	08/15/1996	09/10/1996	0,17100000
Dividends	05/15/1996	06/10/1996	0,17100000
Dividends	02/15/1996	03/11/1996	0,17100000
Dividends	11/15/1995	12/11/1995	0,17125000
Dividends	08/15/1995	09/11/1995	0,16125000
Dividends	05/15/1995	06/12/1995	0,16125000
Dividends	02/15/1995	03/10/1995	0,16125000
Dividends	11/15/1994	12/12/1994	0,15625000
Dividends	08/15/1994	09/12/1994	0,15625000
Dividends	05/13/1994	06/10/1994	0,15625000
Dividends	02/15/1994	03/10/1994	0,15625000
Dividends	11/15/1993	12/10/1993	0,15125000
Dividends	08/13/1993	09/10/1993	0,15125000
Dividends	05/14/1993	06/10/1993	0,15125000
Dividends	02/16/1993	03/10/1993	0,15125000
Dividends	11/13/1992	12/10/1992	0,13750000
Dividends	08/14/1992	09/10/1992	0,13750000
Dividends	05/15/1992	06/10/1992	0,13750000
Dividends	02/14/1992	03/10/1992	0,13750000
Dividends	11/15/1991	12/10/1991	0,12500000
Dividends	08/15/1991	09/10/1991	0,12500000
Dividends	05/15/1991	06/08/1991	0,12500000
Dividends	02/13/1991	03/09/1991	0,12500000
Dividends	11/15/1990	12/08/1990	0,10250000
Dividends	08/15/1990	09/08/1990	0,10250000
Dividends	05/15/1990	06/09/1990	0,10250000
Dividends	02/15/1990	03/10/1990	0,10250000

ABOUT Eli Lilly

Eli Lilly and Compay

Average Investor10 user rating

4.0 (401 people)

United States

125 years

Founded: 1901

1970

Time since IPO - 56 years

35.000

Employees

Eli Lilly and Company is a U.S.-based pharmaceutical company headquartered in Indianapolis, Indiana. Founded in the late 19th century by chemist Eli Lilly, the company operates within the Health Care sector, primarily in the pharmaceuticals industry.

Lilly focuses on the research, development, and commercialization of prescription medicines targeting chronic and complex diseases. Its therapeutic areas include:

Diabetes and Metabolic Disorders: Including insulin therapies and treatments for type 2 diabetes and related metabolic conditions.
Oncology: Medicines for various types of cancer across solid tumors and hematologic conditions.
Neuroscience: Treatments for neurological and psychiatric disorders, including neurodegenerative diseases.
Immunology: Therapies for autoimmune conditions such as rheumatoid arthritis and psoriasis.

The company operates globally, serving patients in more than 100 countries through research facilities, manufacturing sites, and commercial operations worldwide. Lilly follows a research-intensive business model, allocating substantial resources to research and development to support innovation and long-term pipeline growth.

Strategic collaborations with biotechnology firms, research institutions, and healthcare partners further support the advancement of new therapeutic solutions. Eli Lilly’s shares are traded on the New York Stock Exchange under the ticker LLY.

History and Development

Eli Lilly and Company was founded with the objective of producing high-quality, scientifically formulated medicines at a time when pharmaceutical standards were inconsistent. Early adoption of standardized manufacturing practices helped establish the company’s reputation for reliability and innovation.

Over time, Lilly expanded its product portfolio and became a major participant in key therapeutic breakthroughs, including the commercialization of insulin and the development of treatments for psychiatric and cardiovascular conditions.

The company later strengthened its focus on biotechnology-driven drug development, broadening its presence in oncology, immunology, and neuroscience.

In recent years, Eli Lilly has intensified investment in metabolic disease treatments, oncology therapies, and neurodegenerative research, while advancing its pipeline through both internal development and strategic acquisitions.

Today, Eli Lilly is recognized as one of the leading global pharmaceutical companies, with a strong emphasis on scientific research, innovation, and long-term therapeutic advancement.

Additional Information

Eli Lilly and Compay (United States) is listed on the NYSE and has a market capitalization of $837.34 Billions, with shareholders equity totaling $23.85 Billions.

The company employs approximately 35.000 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Eli Lilly and Compay reported $65.18 Billions in revenue, generating net income of $20.64 Billions.

Key financial metrics include a P/E ratio of 40.57, a price-to-book (P/B) ratio of 35.11, and a trailing twelve-month dividend yield of 0.67%.

The company trades under the ticker LLY.

Market cap

$ 837.34 Billions

Net worth

$ 23.85 Billions

$ 23,850,800,000.00

Assets

$ -

Total Shares Outstanding

895.00 Millions

895,000,000

Average Daily Trading Volume

$ 3.19 Millions

$ 3,193,906.46

Sector

Health

Industry

Pharmaceutical Products

LLY

revenue by Business Segment Eli Lilly

Revenue by Region Eli Lilly

LLY revenue and profits

Financial Results LLY

DRAG THE FRAME TO SEE MORE DATA

LLY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34

TMO - Thermo Fisher Scientific

$ 503.56 18,34% (12M)

P/E

27.56

0.35%

ROE

12.52%

P/BV

3.45

LBPSW - 4D pharma

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-300.00%

P/VP

0.00

CVS - CVS Health

$ 79.16 20,24% (12 M)

P/L

52.79

3.62%

ROE

2.35%

P/VP

1.24

CI - Cigna

$ 278.37 --13,14% (12 M)

P/L

10.45

2.26%

ROE

0.00%

P/VP

0.00

CNC - Centene

$ 37.27 --40,26% (12 M)

P/L

-2.59

0.00%

ROE

-33.28%

P/VP

0.86

HUM - Humana

$ 197.45 --30,67% (12 M)

P/L

17.96

1.99%

ROE

6.70%

P/VP

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12 M)

P/L

15.86

0.62%

ROE

-244.82%

P/VP

-38.82

NVS - Novartis

$ 155.47 58,82% (12 M)

P/L

21.09

4.53%

ROE

30.04%

P/VP

6.34

TMO - Thermo Fisher Scientific

$ 503.56 18,34% (12 M)

P/L

27.56

0.35%

ROE

12.52%

P/VP

3.45

Frequently Asked Questions

What is the price of Eli Lilly (LLY) today?

The current price of Eli Lilly (LLY) is $ 959.08, representing a 34.01% gain over the past year. The stock began the year trading around $ 1,074.68 and is currently priced at $ 959.08. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Eli Lilly (LLY) pay dividends?

In the last year, Eli Lilly (LLY) distributed dividends in the month of March, totaling $ 1.73. The Dividend Yield for the last 12 months is 0.67%.

Is Eli Lilly (LLY) a good investment?

Eli Lilly (LLY) is currently trading at $ 959.08 with a P/E ratio of 40.57%. This represents a 6,392% premium compared to its historical average P/E. Over the past year, the stock has gained 34.01 and paid $ 1.73 in dividends, resulting in a dividend yield of 0.67%. The total shareholder return over the same period was 34.01%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Eli Lilly (LLY) stock?

You can buy Eli Lilly (LLY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol LLY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Eli Lilly (LLY) yield today?

Over the past month, Eli Lilly (LLY) has returned -4.22% — 34.01% over the past year, and 454.34% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 6.23 per share in dividends, resulting in a dividend yield of 0.67%.

If you were to purchase 100 shares of Eli Lilly (LLY) today at the current price of $ 959.08 your total investment would be $ 95,908.00.

Based on historical performance, the investment would have grown to approximately:

$ 128,526.31 after 1 year
$ 531,656.41 after 5 years
$ 1,456,765.79 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LLY

Eli Lilly and Compay

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LLY

review the fundamentals of Eli Lilly shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 0.67%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT Eli Lilly

Eli Lilly and Compay

United States

125 years

1970

35.000

History and Development

Additional Information

PROFIT X PRICE LLY

Financial Results LLY

LLY cash flow

Asset, Revenue and Profit Growth - LLY

LLY balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

NVS - Novartis

TMO - Thermo Fisher Scientific

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

HCA - HCA Healthcare

NVS - Novartis

TMO - Thermo Fisher Scientific

Frequently Asked Questions